AJ 3
Alternative Names: AJ-3Latest Information Update: 19 Apr 2024
At a glance
- Originator A&J Science
- Class Antituberculars
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Tuberculosis
Most Recent Events
- 01 Apr 2024 Early research in Tuberculosis in South Korea (unspecified route) prior to April 2024 (A&J Science pipeline, April 2024)